Skip to content
10-Q

Quarterly Report

IMMUNOVANT, INC. IMVT

0001764013-26-000011

← back to feed
Filed
Feb 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Feb 2, 2026 203.53M sh
Shares Diluted Q3 2026 · Dec 31, 2025 181.51M sh
Shares Diluted Q3 2026 · Dec 31, 2025 175.41M sh
Shares Diluted Q3 2026 · Dec 31, 2024 146.92M sh
Shares Diluted Q3 2026 · Dec 31, 2024 146.56M sh
Capex Q3 2026 · Dec 31, 2025 $0
Capex Q3 2026 · Dec 31, 2024 $558K
Operating Cash Flow Q3 2026 · Dec 31, 2025 −$312.25M
Operating Cash Flow Q3 2026 · Dec 31, 2024 −$265.24M
Cash And Equivalents Q3 2026 · Dec 31, 2025 $994.53M
Cash And Equivalents Q3 2026 · Mar 31, 2025 $713.97M
Stockholders Equity Q3 2026 · Dec 31, 2025 $986.14M
Stockholders Equity Q3 2026 · Sep 30, 2025 $519.71M
Stockholders Equity Q3 2026 · Jun 30, 2025 $608.54M
Stockholders Equity Q3 2026 · Mar 31, 2025 $707.45M
Stockholders Equity Q3 2026 · Dec 31, 2024 $352.62M
Stockholders Equity Q3 2026 · Sep 30, 2024 $449.05M
Stockholders Equity Q3 2026 · Jun 30, 2024 $544.66M
Stockholders Equity Q3 2026 · Mar 31, 2024 $617.76M
Current Liabilities Q3 2026 · Dec 31, 2025 $66.26M
Current Liabilities Q3 2026 · Mar 31, 2025 $68.78M
Total Liabilities Q3 2026 · Dec 31, 2025 $66.26M
Total Liabilities Q3 2026 · Mar 31, 2025 $68.78M
Current Assets Q3 2026 · Dec 31, 2025 $1.04B
Current Assets Q3 2026 · Mar 31, 2025 $767.76M
Total Assets Q3 2026 · Dec 31, 2025 $1.05B
Total Assets Q3 2026 · Mar 31, 2025 $776.22M
Eps Diluted Q3 2026 · Dec 31, 2025 −$0.61
Eps Diluted Q3 2026 · Dec 31, 2025 −$2.04
Eps Diluted Q3 2026 · Dec 31, 2024 −$0.76
Eps Diluted Q3 2026 · Dec 31, 2024 −$2.10
Eps Basic Q3 2026 · Dec 31, 2025 −$0.61
Eps Basic Q3 2026 · Dec 31, 2025 −$2.04
Eps Basic Q3 2026 · Dec 31, 2024 −$0.76
Eps Basic Q3 2026 · Dec 31, 2024 −$2.10
Sga Expense Q3 2026 · Dec 31, 2025 $15.44M
Sga Expense Q3 2026 · Dec 31, 2025 $58.98M
Sga Expense Q3 2026 · Dec 31, 2024 $19.78M
Sga Expense Q3 2026 · Dec 31, 2024 $57.06M
Net Income Q3 2026 · Dec 31, 2025 −$110.64M
Net Income Q3 2026 · Dec 31, 2025 −$357.75M
Net Income Q3 2026 · Sep 30, 2025 −$126.5M
Net Income Q3 2026 · Jun 30, 2025 −$120.61M
Net Income Q3 2026 · Dec 31, 2024 −$111.12M
Net Income Q3 2026 · Dec 31, 2024 −$307.39M
Net Income Q3 2026 · Sep 30, 2024 −$109.12M
Net Income Q3 2026 · Jun 30, 2024 −$87.15M